InsidersTradesSigma
Carasent Stock: price and insider trades · Finland · FIN-FSA
Track the Carasent stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are quoted on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, Carasent has recorded 0 reports. Market capitalisation: €1.6bn. All data is accessible without an account.
n/a
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Carasent Strong Buy (bullish), based on 2 analysts. Average price target: SEK 34.75.
Fundamental score
Ranked 12,178 of 28,016 companies
55.3
score / 100
Value38
Quality73
FCF yld-0.0%
Earn yld2.2%
EV/EBITDA16.9x
ROE5.2%
Gross mgn84%
Net mgn10%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Declarations0 total
No declarations found
0 of 0 declarations
About Carasent
Carasent is a company focused on the healthcare and pharmaceutical sector, providing innovative solutions to enhance patient care. It is listed on the XSTO exchange.